Accepted for/Published in: JMIR Mental Health
Date Submitted: Aug 25, 2022
Date Accepted: Sep 19, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
FiRst EpisodE Digital Monitoring (FREEDoM): A Qualitative Study to Inform the Development of a Novel mHealth Intervention for People with Early Psychosis
ABSTRACT
Background:
Mobile health (mHealth) technologies have been used extensively in psychosis research. In contrast, their integration into clinical care has been sparse, despite substantial increase in the availability of smartphone-based apps targeting mental health care. One potential reason is that few of these apps have been developed with input from stakeholders (e.g., clinicians), the primary users of data from such applications, making their integration into routine clinical care challenging.
Objective:
This qualitative study sought clinicians’ input to inform the adaptation of FREEDoM, an app-based mHealth intervention designed to enhance treatment of patients with first-episode psychosis (FEP).
Methods:
The FREEDoM app was developed to enhance the quality, quantity, and timeliness of clinical and functional data available to clinicians and patients in order to enhance their therapeutic relationship and increase shared decision-making. Following the app’s initial development, semi-structured qualitative interviews were conducted with 11 FEP treatment providers at three sites to elicit input on the app. We then conducted summary template and matrix analysis to systematically categorize suggested adaptations using dimension of the Framework for Reporting Adaptations and Modifications to Evidence-based interventions (FRAME) and documented the rationale for adopting/rejecting suggestions.
Results:
The clinicians provided 31 suggestions (18 adopted, 13 rejected). Suggestions to add/refine content were most common (e.g., adding questions within the app). Adaptations to context were most often related to plans for implementing the intervention, how reported data were displayed to clinicians, and with whom reports were shared. Reasons for suggestions primarily included factors related to clients’ health narratives/priorities (e.g., symptom’s functional impact vs. their frequency/severity), providers’ clinical judgment (e.g., need for clinically relevant information), and organizations’ mission/culture. Reasons for rejecting suggestions included need for resources beyond intervention scope, concerns regarding dilution of the intervention core components, and increasing patient burden.
Conclusions:
This study describes the development of the FREEDoM app, an innovative stakeholder-informed intervention designed to enhance treatment for individuals with FEP. Our study illustrates a pragmatic application of the FRAME and provides methods and tools for rapid analysis to track adaptations and related decision-making processes, potentially contributing to its acceptance and use in clinical care. Clinical Trial: Trial registration: ClinicalTrials.gov #NCT04248517, registered Jan. 30, 2020 https://clinicaltrials.gov/ct2/show/NCT04248517?term=using+mhealth&draw=2&rank=4
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.